US Stock MarketDetailed Quotes

MDT Medtronic

Watchlist
  • 90.480
  • +0.310+0.34%
Close Feb 25 16:00 ET
  • 90.550
  • +0.070+0.08%
Post 20:01 ET
116.11BMarket Cap27.59P/E (TTM)

Medtronic Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jan 24, 2025
(Q2)Oct 25, 2024
(Q1)Jul 26, 2024
(FY)Apr 26, 2024
(Q4)Apr 26, 2024
(Q3)Jan 26, 2024
(Q2)Oct 27, 2023
(Q1)Jul 28, 2023
(FY)Apr 28, 2023
(Q4)Apr 28, 2023
Total revenue
2.51%8.29B
5.25%8.4B
2.77%7.92B
3.64%32.36B
0.51%8.59B
4.68%8.09B
5.26%7.98B
4.49%7.7B
-1.45%31.23B
5.64%8.55B
Operating revenue
2.51%8.29B
5.25%8.4B
2.77%7.92B
3.64%32.36B
0.51%8.59B
4.68%8.09B
5.26%7.98B
4.49%7.7B
-1.45%31.23B
5.64%8.55B
Cost of revenue
-0.11%2.78B
6.70%2.95B
5.06%2.76B
4.64%11.22B
2.18%3.04B
3.46%2.78B
8.92%2.76B
4.45%2.63B
5.66%10.72B
14.97%2.98B
Gross profit
3.88%5.51B
4.48%5.46B
1.58%5.15B
3.12%21.15B
-0.38%5.55B
5.34%5.31B
3.43%5.22B
4.51%5.07B
-4.80%20.51B
1.24%5.57B
Operating expense
-0.03%3.8B
1.46%3.83B
0.94%3.75B
6.47%15.63B
16.06%4.34B
5.40%3.8B
4.45%3.78B
-0.16%3.71B
-6.11%14.68B
-1.66%3.74B
Selling and administrative expenses
1.65%2.72B
2.64%2.76B
1.61%2.66B
3.08%10.74B
5.70%2.77B
2.22%2.67B
2.64%2.69B
1.79%2.61B
1.20%10.42B
1.83%2.62B
Research and development costs
-2.88%675M
-0.14%697M
1.20%676M
1.45%2.74B
5.30%675M
1.02%695M
3.25%698M
-3.47%668M
-1.82%2.7B
-1.69%641M
Depreciation amortization depletion
-0.72%416M
-2.82%413M
-3.50%414M
-0.29%1.69B
-0.95%419M
-2.78%419M
0.95%425M
1.42%429M
-2.02%1.7B
-2.76%423M
-Depreciation and amortization
-0.72%416M
-2.82%413M
-3.50%414M
-0.29%1.69B
-0.95%419M
-2.78%419M
0.95%425M
1.42%429M
-2.02%1.7B
-2.76%423M
Other operating expenses
-129.41%-5M
-9.68%-34M
0.00%1M
454.20%464M
751.79%477M
113.60%17M
68.04%-31M
-97.14%1M
-115.20%-131M
-60.84%56M
Operating profit
13.77%1.71B
12.39%1.62B
3.30%1.41B
-5.32%5.52B
-33.93%1.21B
5.18%1.5B
0.84%1.45B
19.77%1.36B
-1.32%5.83B
7.71%1.83B
Net non-operating interest income expense
4.79%-179M
-16.11%-209M
-12.84%-167M
-13.05%-719M
-8.02%-202M
-12.57%-188M
-52.54%-180M
9.76%-148M
-15.01%-636M
-30.77%-187M
Non-operating interest expense
-4.79%179M
16.11%209M
12.84%167M
13.05%719M
8.02%202M
12.57%188M
52.54%180M
-9.76%148M
15.01%636M
30.77%187M
Other net income (expense)
-95.54%7M
191.84%143M
261.11%29M
-78.24%37M
-65.93%-151M
41.44%157M
-37.97%49M
-126.09%-18M
4.29%170M
-297.83%-91M
Special income (charges)
-225.00%-65M
71.43%-30M
-36.17%-128M
-8.70%-375M
40.91%-156M
47.37%-20M
-250.00%-105M
-571.43%-94M
-122.58%-345M
-842.86%-264M
-Less：Restructuring and merger&acquisition
115.00%43M
-25.00%30M
-12.96%47M
-39.73%226M
-61.90%112M
-47.37%20M
33.33%40M
285.71%54M
525.00%375M
950.00%294M
-Less:Other special charges
--22M
----
102.50%81M
596.67%149M
--44M
----
--65M
--40M
-131.58%-30M
----
Other non- operating income (expenses)
-59.32%72M
12.34%173M
106.58%157M
-20.00%412M
-97.11%5M
18.79%177M
41.28%154M
-8.43%76M
61.95%515M
133.78%173M
Income before tax
4.62%1.54B
18.74%1.56B
6.02%1.27B
-9.82%4.84B
-44.87%855M
7.05%1.47B
-5.88%1.31B
14.56%1.2B
-2.77%5.36B
-3.18%1.55B
Income tax
75.56%237M
-30.10%281M
-45.00%220M
-28.29%1.13B
-45.58%197M
-7.53%135M
-58.08%402M
257.14%400M
246.49%1.58B
229.09%362M
Net income
-2.54%1.3B
40.29%1.28B
31.62%1.05B
-2.09%3.71B
-44.49%660M
8.79%1.34B
109.43%911M
-14.39%797M
-25.25%3.78B
-20.31%1.19B
Net income continuous Operations
-2.54%1.3B
40.29%1.28B
31.62%1.05B
-2.09%3.71B
-44.49%660M
8.79%1.34B
109.43%911M
-14.48%797M
-25.25%3.78B
-20.31%1.19B
Minority interest income
-40.00%9M
350.00%9M
0.00%6M
7.69%28M
-44.44%5M
150.00%15M
-75.00%2M
200.00%6M
18.18%26M
50.00%9M
Net income attributable to the parent company
-2.12%1.29B
39.71%1.27B
31.73%1.04B
-2.18%3.68B
-44.53%654M
8.18%1.32B
112.88%909M
-14.85%791M
-25.42%3.76B
-20.61%1.18B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-2.12%1.29B
39.71%1.27B
31.73%1.04B
-2.18%3.68B
-44.53%654M
8.18%1.32B
112.88%909M
-14.85%791M
-25.42%3.76B
-20.61%1.18B
Basic earnings per share
2.02%1.01
45.59%0.99
37.29%0.81
-2.12%2.77
-44.94%0.49
7.61%0.99
112.50%0.68
-15.71%0.59
-24.53%2.83
-19.82%0.89
Diluted earnings per share
2.02%1.01
45.59%0.99
35.59%0.8
-2.13%2.76
-44.32%0.49
7.61%0.99
112.50%0.68
-15.71%0.59
-24.40%2.82
-20.00%0.88
Dividend per share
1.45%0.7
1.45%0.7
1.45%0.7
1.47%2.76
1.47%0.69
1.47%0.69
1.47%0.69
1.47%0.69
7.94%2.72
7.94%0.68
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Jan 24, 2025(Q2)Oct 25, 2024(Q1)Jul 26, 2024(FY)Apr 26, 2024(Q4)Apr 26, 2024(Q3)Jan 26, 2024(Q2)Oct 27, 2023(Q1)Jul 28, 2023(FY)Apr 28, 2023(Q4)Apr 28, 2023
Total revenue 2.51%8.29B5.25%8.4B2.77%7.92B3.64%32.36B0.51%8.59B4.68%8.09B5.26%7.98B4.49%7.7B-1.45%31.23B5.64%8.55B
Operating revenue 2.51%8.29B5.25%8.4B2.77%7.92B3.64%32.36B0.51%8.59B4.68%8.09B5.26%7.98B4.49%7.7B-1.45%31.23B5.64%8.55B
Cost of revenue -0.11%2.78B6.70%2.95B5.06%2.76B4.64%11.22B2.18%3.04B3.46%2.78B8.92%2.76B4.45%2.63B5.66%10.72B14.97%2.98B
Gross profit 3.88%5.51B4.48%5.46B1.58%5.15B3.12%21.15B-0.38%5.55B5.34%5.31B3.43%5.22B4.51%5.07B-4.80%20.51B1.24%5.57B
Operating expense -0.03%3.8B1.46%3.83B0.94%3.75B6.47%15.63B16.06%4.34B5.40%3.8B4.45%3.78B-0.16%3.71B-6.11%14.68B-1.66%3.74B
Selling and administrative expenses 1.65%2.72B2.64%2.76B1.61%2.66B3.08%10.74B5.70%2.77B2.22%2.67B2.64%2.69B1.79%2.61B1.20%10.42B1.83%2.62B
Research and development costs -2.88%675M-0.14%697M1.20%676M1.45%2.74B5.30%675M1.02%695M3.25%698M-3.47%668M-1.82%2.7B-1.69%641M
Depreciation amortization depletion -0.72%416M-2.82%413M-3.50%414M-0.29%1.69B-0.95%419M-2.78%419M0.95%425M1.42%429M-2.02%1.7B-2.76%423M
-Depreciation and amortization -0.72%416M-2.82%413M-3.50%414M-0.29%1.69B-0.95%419M-2.78%419M0.95%425M1.42%429M-2.02%1.7B-2.76%423M
Other operating expenses -129.41%-5M-9.68%-34M0.00%1M454.20%464M751.79%477M113.60%17M68.04%-31M-97.14%1M-115.20%-131M-60.84%56M
Operating profit 13.77%1.71B12.39%1.62B3.30%1.41B-5.32%5.52B-33.93%1.21B5.18%1.5B0.84%1.45B19.77%1.36B-1.32%5.83B7.71%1.83B
Net non-operating interest income expense 4.79%-179M-16.11%-209M-12.84%-167M-13.05%-719M-8.02%-202M-12.57%-188M-52.54%-180M9.76%-148M-15.01%-636M-30.77%-187M
Non-operating interest expense -4.79%179M16.11%209M12.84%167M13.05%719M8.02%202M12.57%188M52.54%180M-9.76%148M15.01%636M30.77%187M
Other net income (expense) -95.54%7M191.84%143M261.11%29M-78.24%37M-65.93%-151M41.44%157M-37.97%49M-126.09%-18M4.29%170M-297.83%-91M
Special income (charges) -225.00%-65M71.43%-30M-36.17%-128M-8.70%-375M40.91%-156M47.37%-20M-250.00%-105M-571.43%-94M-122.58%-345M-842.86%-264M
-Less：Restructuring and merger&acquisition 115.00%43M-25.00%30M-12.96%47M-39.73%226M-61.90%112M-47.37%20M33.33%40M285.71%54M525.00%375M950.00%294M
-Less:Other special charges --22M----102.50%81M596.67%149M--44M------65M--40M-131.58%-30M----
Other non- operating income (expenses) -59.32%72M12.34%173M106.58%157M-20.00%412M-97.11%5M18.79%177M41.28%154M-8.43%76M61.95%515M133.78%173M
Income before tax 4.62%1.54B18.74%1.56B6.02%1.27B-9.82%4.84B-44.87%855M7.05%1.47B-5.88%1.31B14.56%1.2B-2.77%5.36B-3.18%1.55B
Income tax 75.56%237M-30.10%281M-45.00%220M-28.29%1.13B-45.58%197M-7.53%135M-58.08%402M257.14%400M246.49%1.58B229.09%362M
Net income -2.54%1.3B40.29%1.28B31.62%1.05B-2.09%3.71B-44.49%660M8.79%1.34B109.43%911M-14.39%797M-25.25%3.78B-20.31%1.19B
Net income continuous Operations -2.54%1.3B40.29%1.28B31.62%1.05B-2.09%3.71B-44.49%660M8.79%1.34B109.43%911M-14.48%797M-25.25%3.78B-20.31%1.19B
Minority interest income -40.00%9M350.00%9M0.00%6M7.69%28M-44.44%5M150.00%15M-75.00%2M200.00%6M18.18%26M50.00%9M
Net income attributable to the parent company -2.12%1.29B39.71%1.27B31.73%1.04B-2.18%3.68B-44.53%654M8.18%1.32B112.88%909M-14.85%791M-25.42%3.76B-20.61%1.18B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -2.12%1.29B39.71%1.27B31.73%1.04B-2.18%3.68B-44.53%654M8.18%1.32B112.88%909M-14.85%791M-25.42%3.76B-20.61%1.18B
Basic earnings per share 2.02%1.0145.59%0.9937.29%0.81-2.12%2.77-44.94%0.497.61%0.99112.50%0.68-15.71%0.59-24.53%2.83-19.82%0.89
Diluted earnings per share 2.02%1.0145.59%0.9935.59%0.8-2.13%2.76-44.32%0.497.61%0.99112.50%0.68-15.71%0.59-24.40%2.82-20.00%0.88
Dividend per share 1.45%0.71.45%0.71.45%0.71.47%2.761.47%0.691.47%0.691.47%0.691.47%0.697.94%2.727.94%0.68
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Hunan Creator Information Technologies
300730
+20.03%
Shandong Rike Chemical
300214
+20.03%
Jiangsu LiXing General Steel Ball
300421
+20.03%
4
Jiangsu Boiln Plastics
301003
+20.00%
5
Ningbo Henghe Precision Industry
300539
+20.00%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.